Henrik E. Poulsen

Overview

Best Publications

• Cancer risk and oxidative DNA damage in man

  Steffen Loft;H E Poulsen

  1319
  Citations

• Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

  Morten L. Hansen;Rikke Sørensen;Mette T. Clausen;Marie Louise Fog-Petersen

  1033
  Citations

• The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors: A Randomized Trial

  María-Isabel Covas;Kristiina Nyyssönen;Henrik E. Poulsen;Jari Kaikkonen

  981
  Citations

• The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors

  Maria-Isabel Covas;Henrik E. Poulsen;Jari Kaikkonen;Hans-Joachim F. Zunft

  889
  Citations

• Clinical Relevance of Biomarkers of Oxidative Stress

  Jeroen Frijhoff;Paul Graham Winyard;Neven Zarkovic;Sean Ss Davies

  856
  Citations

• Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index.

  Steffen Loft;Kirsten Vistisen;Marianne Ewertz;Anne Tjønneland

  756
  Citations

• Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008.

  J. López-Miranda;F. Pérez-Jiménez;E. Ros;R. De Caterina

  676
  Citations

• Role of oxidative DNA damage in cancer initiation and promotion.

  H E Poulsen;H Prieme;S Loft

  535
  Citations

• Fluvoxamine is a potent inhibitor of cytochrome P4501A2

  Kim Brøsen;Erik Skjelbo;Birgitte B. Rasmussen;Henrik E. Poulsen

  454
  Citations

• Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study

  Riitta M. Salonen;Kristiina Nyyssönen;Jari Kaikkonen;Elina Porkkala-Sarataho

  445
  Citations

• Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.

  J T Salonen;K Nyyssönen;R Salonen;H M Lakka

  440
  Citations

• Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.

  U. Jeppesen;L. F. Gram;K. Vistisen;S. Loft

  423
  Citations

• Enzymatic determination of uric acid; with detailed directions.

  E. Prætorius;H. Poulsen

  404
  Citations

• Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?

  Andrew R Collins;Jean Cadet;Lennart Möller;Henrik E Poulsen

  387
  Citations

• Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

  Gunnar H. Gislason;Jeppe N. Rasmussen;Steen Z. Abildstrom;Tina K. Schramm

  369
  Citations

• Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry.

  Allan Weimann;Dorthe Belling;Henrik E. Poulsen

  345
  Citations

• Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation

  Oana Ciofu;Bente Riis;Tacjana Pressler;Henrik Enghusen Poulsen

  343
  Citations

• European contribution to the study of ROS : a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

  Javier Egea;Isabel Fabregat;Yves M Frapart;Pietro Ghezzi

  327
  Citations

• The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

  Erik J.M. van Bommel;Marcel H.A. Muskiet;Michaël J.B. van Baar;Lennart Tonneijck

  306
  Citations

• 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage

  Steffen Loft;Anne Fischer‐Nielsen;Inge B. Jeding;Kirsten Vistisen

  302
  Citations